Parexel-consulting
Is this your brand? Claim it — free, and takes a minute with your work email.
Overview
Tagline Brand's website · 2026-10-04
A patient-first approach integrating patient insights into trial design, 8,000+ global oncology staff, 29,900+ worldwide clinical trial sites, 1,300+ regulatory specialists (including former regulators), advanced modeling and simulation capabilities, and efficient real-world data application for patient recruitment.
Description Brand's website · 2026-10-04
Parexel Consulting, a division of Parexel, offers comprehensive clinical development services from Phase I to IV, specializing in oncology trials. They provide regulatory and therapeutic expertise, advanced modeling, patient recruitment, and a global network of sites to accelerate drug development with a patient-first approach.
Offerings
Core capabilities Brand's website · 2026-10-04
- Full range of Phase I to IV clinical development services
- oncology clinical trial design and execution
- regulatory affairs consulting
- patient recruitment and retention solutions
- advanced modeling and simulation for drug development.
Pricing Brand's website · 2026-10-04
Service-based, project-based engagements.
Audience
Target industry Brand's website · 2026-10-04
Biopharmaceutical companies, pharmaceutical leaders, biotechnology firms, and clinical trial sites globally, seeking to accelerate drug development and ensure regulatory compliance.
Is this your business?
The information above is publicly sourced — assembled by Optimly from Parexel-consulting's website and public pages.
Claim this profile to publish your own verified Business Profile and speak for Parexel-consulting across the index.
Claim Parexel-consulting — free →Page last updated 2026-10-17.